These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 12218414)

  • 1. Grey matter and white matter ischemic damage is reduced by the competitive AMPA receptor antagonist, SPD 502.
    McCracken E; Fowler JH; Dewar D; Morrison S; McCulloch J
    J Cereb Blood Flow Metab; 2002 Sep; 22(9):1090-7. PubMed ID: 12218414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPD 502: a water-soluble and in vivo long-lasting AMPA antagonist with neuroprotective activity.
    Nielsen EO; Varming T; Mathiesen C; Jensen LH; Moller A; Gouliaev AH; Wätjen F; Drejer J
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1492-501. PubMed ID: 10336544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ebselen protects both gray and white matter in a rodent model of focal cerebral ischemia.
    Imai H; Masayasu H; Dewar D; Graham DI; Macrae IM
    Stroke; 2001 Sep; 32(9):2149-54. PubMed ID: 11546910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effect of the AMPA receptor antagonist LY-293558 in focal cerebral ischemia in the cat.
    Bullock R; Graham DI; Swanson S; McCulloch J
    J Cereb Blood Flow Metab; 1994 May; 14(3):466-71. PubMed ID: 8163588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed treatment with YM90K, an AMPA receptor antagonist, protects against ischaemic damage after middle cerebral artery occlusion in rats.
    Kawasaki-Yatsugi S; Shimizu-Sasamata M; Yatsugi S; Yamaguchi T
    J Pharm Pharmacol; 1998 Aug; 50(8):891-8. PubMed ID: 9751454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative assessment of ischemic pathology in axons, oligodendrocytes, and neurons: attenuation of damage after transient ischemia.
    Valeriani V; Dewar D; McCulloch J
    J Cereb Blood Flow Metab; 2000 May; 20(5):765-71. PubMed ID: 10826526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of cerebral infarct size by non-competitive AMPA antagonists in rats subjected to permanent and transient focal ischemia.
    Matucz E; Móricz K; Gigler G; Simó A; Barkóczy J; Lévay G; Hársing LG; Szénási G
    Brain Res; 2004 Sep; 1019(1-2):210-6. PubMed ID: 15306255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effects of an AMPA receptor antagonist YM872 in a rat transient middle cerebral artery occlusion model.
    Kawasaki-Yatsugi S; Ichiki C; Yatsugi S; Takahashi M; Shimizu-Sasamata M; Yamaguchi T; Minematsu K
    Neuropharmacology; 2000 Jan; 39(2):211-7. PubMed ID: 10670416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cilostazol attenuates gray and white matter damage in a rodent model of focal cerebral ischemia.
    Honda F; Imai H; Ishikawa M; Kubota C; Shimizu T; Fukunaga M; Saito N
    Stroke; 2006 Jan; 37(1):223-8. PubMed ID: 16339464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel AMPA receptor antagonist, YM872, reduces infarct size after middle cerebral artery occlusion in rats.
    Kawasaki-Yatsugi S; Yatsugi S; Takahashi M; Toya T; Ichiki C; Shimizu-Sasamata M; Yamaguchi T; Minematsu K
    Brain Res; 1998 May; 793(1-2):39-46. PubMed ID: 9630503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracerebral injection of AMPA causes axonal damage in vivo.
    Fowler JH; McCracken E; Dewar D; McCulloch J
    Brain Res; 2003 Nov; 991(1-2):104-12. PubMed ID: 14575882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YM90K, an AMPA receptor antagonist, protects against ischemic damage caused by permanent and transient middle cerebral artery occlusion in rats.
    Kawasaki-Yatsugi S; Ichiki C; Yatsugi S; Shimizu-Sasamata M; Yamaguchi T
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Nov; 358(5):586-91. PubMed ID: 9840429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lipid peroxidation by-product 4-hydroxynonenal is toxic to axons and oligodendrocytes.
    McCracken E; Valeriani V; Simpson C; Jover T; McCulloch J; Dewar D
    J Cereb Blood Flow Metab; 2000 Nov; 20(11):1529-36. PubMed ID: 11083227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMDA receptor blockade fails to alter axonal injury in focal cerebral ischemia.
    Yam PS; Dunn LT; Graham DI; Dewar D; McCulloch J
    J Cereb Blood Flow Metab; 2000 May; 20(5):772-9. PubMed ID: 10826527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia.
    Nellgård B; Wieloch T
    J Cereb Blood Flow Metab; 1992 Jan; 12(1):2-11. PubMed ID: 1345757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The N-methyl-D-aspartate antagonist CNS 1102 protects cerebral gray and white matter from ischemic injury following temporary focal ischemia in rats.
    Schäbitz WR; Li F; Fisher M
    Stroke; 2000 Jul; 31(7):1709-14. PubMed ID: 10884477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuroprotective effect of the novel AMPA receptor antagonist PD152247 (PNQX) in temporary focal ischemia in the rat.
    Schielke GP; Kupina NC; Boxer PA; Bigge CF; Welty DF; Iadecola C
    Stroke; 1999 Jul; 30(7):1472-7. PubMed ID: 10390325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YM872, a novel selective alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, reduces brain damage after permanent focal cerebral ischemia in cats.
    Takahashi M; Ni JW; Kawasaki-Yatsugi S; Toya T; Yatsugi SI; Shimizu-Sasamata M; Koshiya K; Shishikura JI; Sakamoto S; Yamaguchi T
    J Pharmacol Exp Ther; 1998 Feb; 284(2):467-73. PubMed ID: 9454786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin attenuates gray and white matter damage in a mouse model of transient focal cerebral ischemia.
    Lee EJ; Lee MY; Chen HY; Hsu YS; Wu TS; Chen ST; Chang GL
    J Pineal Res; 2005 Jan; 38(1):42-52. PubMed ID: 15617536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma.
    Wrathall JR; Teng YD; Marriott R
    Exp Neurol; 1997 Jun; 145(2 Pt 1):565-73. PubMed ID: 9217092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.